Rep. Jared Moskowitz Buys Shares of HCA Healthcare, Inc. (NYSE:HCA)

Representative Jared Moskowitz (Democratic-Florida) recently bought shares of HCA Healthcare, Inc. (NYSE:HCA). In a filing disclosed on July 26th, the Representative disclosed that they had bought between $1,001 and $15,000 in HCA Healthcare stock on June 17th. The trade occurred in the Representative’s “MORGAN STANLEY ACTIVE ASSETS (1)” account.

Representative Jared Moskowitz also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Applied Materials (NASDAQ:AMAT) on 6/18/2026.
• Purchased $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Monster Beverage (NASDAQ:MNST) on 6/17/2026.
• Sold $1,001 – $15,000 in shares of S&P Global (NYSE:SPGI) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 6/17/2026.
• Purchased $1,001 – $15,000 in shares of SpaceX (NASDAQ:SPCX) on 6/12/2026.
• Sold $1,001 – $15,000 in shares of Cencora (NYSE:COR) on 5/6/2026.
• Purchased $1,001 – $15,000 in shares of Gilead Sciences (NASDAQ:GILD) on 5/6/2026.

HCA Healthcare Trading Up 2.3%

Shares of NYSE HCA traded up $9.05 during mid-day trading on Wednesday, hitting $409.78. The company had a trading volume of 1,124,608 shares, compared to its average volume of 1,355,077. The firm has a 50-day simple moving average of $387.44 and a two-hundred day simple moving average of $449.94. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The company has a market capitalization of $88.72 billion, a PE ratio of 13.72, a price-to-earnings-growth ratio of 1.41 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.84 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 29.45 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s payout ratio is presently 10.45%.

Analysts Set New Price Targets

HCA has been the topic of a number of recent analyst reports. TD Cowen decreased their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Wells Fargo & Company increased their target price on shares of HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research report on Monday. Royal Bank Of Canada restated an “outperform” rating and set a $435.00 price objective on shares of HCA Healthcare in a research report on Monday, July 27th. Raymond James Financial set a $528.00 price target on HCA Healthcare in a research note on Tuesday, July 7th. Finally, Morgan Stanley decreased their price target on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a research report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $465.59.

Hedge Funds Weigh In On HCA Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. State Street Corp grew its position in HCA Healthcare by 1.0% in the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after purchasing an additional 76,039 shares during the period. Capital World Investors lifted its stake in HCA Healthcare by 0.8% during the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after acquiring an additional 40,086 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after purchasing an additional 13,565 shares in the last quarter. Norges Bank purchased a new stake in HCA Healthcare in the 4th quarter valued at about $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership boosted its stake in shares of HCA Healthcare by 11.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida’s 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida’s 23rd Congressional District. He declared candidacy for the 2026 election.

Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor’s degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz’s career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.